Bruker (BRKR) Payables (2010 - 2026)

Bruker (BRKR) has reported Payables for 17 consecutive years, with $200.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Payables fell 17.61% year-over-year to $200.2 million; the trailing twelve-month figure through Jun 2026 stood at $200.2 million (down 17.61% YoY), and the FY2025 full-year result was $266.5 million, up 13.4% from the prior year.
• Payables fell to $200.2 million in Q2 2026 per BRKR's latest filing, from $269.1 million in the prior quarter.
• Across five years, Payables topped out at $269.1 million in Q1 2026 and bottomed at $154.9 million in Q2 2022.
• Historically, Payables has averaged $206.3 million across 5 years, with a median of $199.6 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Payables gained 25.34% in 2024, then retreated 18.95% in 2025.
• Over 5 years, Payables stood at $179.3 million in 2022, then advanced by 13.55% to $203.6 million in 2023, then climbed by 15.42% to $235.0 million in 2024, then advanced by 13.4% to $266.5 million in 2025, then dropped by 24.88% to $200.2 million in 2026.
• According to Business Quant data, Payables over the past three periods registered $200.2 million, $269.1 million, and $266.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.